Amgen Statistics
Total Valuation
Amgen has a market cap or net worth of $173.15 billion. The enterprise value is $217.17 billion.
Important Dates
The last earnings date was Tuesday, November 4, 2025, after market close.
| Earnings Date | Nov 4, 2025 |
| Ex-Dividend Date | Nov 21, 2025 |
Share Statistics
Amgen has 538.36 million shares outstanding. The number of shares has increased by 0.23% in one year.
| Current Share Class | 538.36M |
| Shares Outstanding | 538.36M |
| Shares Change (YoY) | +0.23% |
| Shares Change (QoQ) | +0.18% |
| Owned by Insiders (%) | 0.15% |
| Owned by Institutions (%) | 80.95% |
| Float | 537.00M |
Valuation Ratios
The trailing PE ratio is 24.88 and the forward PE ratio is 15.24. Amgen's PEG ratio is 2.76.
| PE Ratio | 24.88 |
| Forward PE | 15.24 |
| PS Ratio | 4.44 |
| Forward PS | 4.65 |
| PB Ratio | 16.59 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 14.30 |
| P/OCF Ratio | 13.11 |
| PEG Ratio | 2.76 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 13.24, with an EV/FCF ratio of 18.05.
| EV / Earnings | 31.00 |
| EV / Sales | 6.04 |
| EV / EBITDA | 13.24 |
| EV / EBIT | 19.58 |
| EV / FCF | 18.05 |
Financial Position
The company has a current ratio of 1.28, with a Debt / Equity ratio of 5.67.
| Current Ratio | 1.28 |
| Quick Ratio | 0.82 |
| Debt / Equity | 5.67 |
| Debt / EBITDA | 3.33 |
| Debt / FCF | 4.54 |
| Interest Coverage | 3.30 |
Financial Efficiency
Return on equity (ROE) is 81.71% and return on invested capital (ROIC) is 10.49%.
| Return on Equity (ROE) | 81.71% |
| Return on Assets (ROA) | 7.66% |
| Return on Invested Capital (ROIC) | 10.49% |
| Return on Capital Employed (ROCE) | 16.22% |
| Revenue Per Employee | $1.28M |
| Profits Per Employee | $250,179 |
| Employee Count | 28,000 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 1.43 |
Taxes
In the past 12 months, Amgen has paid $1.24 billion in taxes.
| Income Tax | 1.24B |
| Effective Tax Rate | 15.03% |
Stock Price Statistics
The stock price has increased by +0.83% in the last 52 weeks. The beta is 0.46, so Amgen's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | +0.83% |
| 50-Day Moving Average | 288.69 |
| 200-Day Moving Average | 291.79 |
| Relative Strength Index (RSI) | 73.69 |
| Average Volume (20 Days) | 2,098,958 |
Short Selling Information
The latest short interest is 11.48 million, so 2.13% of the outstanding shares have been sold short.
| Short Interest | 11.48M |
| Short Previous Month | 12.91M |
| Short % of Shares Out | 2.13% |
| Short % of Float | 2.14% |
| Short Ratio (days to cover) | 4.23 |
Income Statement
In the last 12 months, Amgen had revenue of $35.97 billion and earned $7.01 billion in profits. Earnings per share was $12.93.
| Revenue | 35.97B |
| Gross Profit | 26.20B |
| Operating Income | 11.09B |
| Pretax Income | 8.24B |
| Net Income | 7.01B |
| EBITDA | 16.40B |
| EBIT | 11.09B |
| Earnings Per Share (EPS) | $12.93 |
Full Income StatementBalance Sheet
The company has $9.45 billion in cash and $54.59 billion in debt, giving a net cash position of -$45.14 billion or -$83.85 per share.
| Cash & Cash Equivalents | 9.45B |
| Total Debt | 54.59B |
| Net Cash | -45.14B |
| Net Cash Per Share | -$83.85 |
| Equity (Book Value) | 9.62B |
| Book Value Per Share | 17.88 |
| Working Capital | 6.09B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $13.13 billion and capital expenditures -$1.10 billion, giving a free cash flow of $12.03 billion.
| Operating Cash Flow | 13.13B |
| Capital Expenditures | -1.10B |
| Free Cash Flow | 12.03B |
| FCF Per Share | $22.35 |
Full Cash Flow StatementMargins
Gross margin is 72.83%, with operating and profit margins of 30.83% and 19.47%.
| Gross Margin | 72.83% |
| Operating Margin | 30.83% |
| Pretax Margin | 22.92% |
| Profit Margin | 19.47% |
| EBITDA Margin | 45.59% |
| EBIT Margin | 30.83% |
| FCF Margin | 33.44% |
Dividends & Yields
This stock pays an annual dividend of $9.52, which amounts to a dividend yield of 2.96%.
| Dividend Per Share | $9.52 |
| Dividend Yield | 2.96% |
| Dividend Growth (YoY) | 5.78% |
| Years of Dividend Growth | 15 |
| Payout Ratio | 73.61% |
| Buyback Yield | -0.23% |
| Shareholder Yield | 2.75% |
| Earnings Yield | 4.07% |
| FCF Yield | 6.99% |
Dividend DetailsAnalyst Forecast
The average price target for Amgen is $314.71, which is -2.15% lower than the current price. The consensus rating is "Hold".
| Price Target | $314.71 |
| Price Target Difference | -2.15% |
| Analyst Consensus | Hold |
| Analyst Count | 15 |
| Revenue Growth Forecast (5Y) | 3.48% |
| EPS Growth Forecast (5Y) | 26.33% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on November 22, 1999. It was a forward split with a ratio of 2:1.
| Last Split Date | Nov 22, 1999 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |
